Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report

Banchamlak Tegegne,1 Getaneh Alemu2 1Amhara Public Health Institute, Bahir Dar, Ethiopia; 2Department of Medical Laboratory Science, Bahir Dar University, Bahir Dar, EthiopiaCorrespondence: Getaneh Alemu PO Box 79 Tel +251922842776Email getanehmlt@gmail.comBackground: Leishmaniasis is one of the neg...

Full description

Bibliographic Details
Main Authors: Tegegne B, Alemu G
Format: Article
Language:English
Published: Dove Medical Press 2020-10-01
Series:International Medical Case Reports Journal
Subjects:
Online Access:https://www.dovepress.com/progress-of-mucocutaneous-leishmaniasis-to-drug-nonresponsive-diffuse--peer-reviewed-article-IMCRJ
_version_ 1828836234238099456
author Tegegne B
Alemu G
author_facet Tegegne B
Alemu G
author_sort Tegegne B
collection DOAJ
description Banchamlak Tegegne,1 Getaneh Alemu2 1Amhara Public Health Institute, Bahir Dar, Ethiopia; 2Department of Medical Laboratory Science, Bahir Dar University, Bahir Dar, EthiopiaCorrespondence: Getaneh Alemu PO Box 79 Tel +251922842776Email getanehmlt@gmail.comBackground: Leishmaniasis is one of the neglected tropical diseases, yet it is associated with high mortality and morbidity. It is caused by intracellular protozoan parasites of the genus Leishmania. Based on the infecting parasite species and host factors, leishmaniasis could be manifested as cutaneous (localized or diffuse), mucocutaneous or visceral clinical forms. In Ethiopia, L. aethiopica is well known to cause all forms of cutaneous leishmaniasis, the localized form being mostcommon.Case Presentation: An adult patient from Yayu district, west Oromia region of Ethiopia presents with multiple skin lesions on his face, hands and mutilation of nose through both nostrils. Eight years before the present symptoms, he has developed spontaneously healed cutaneous ulcer on his face leaving a permanent scar. Physical examination revealed multiple nodular lesions on his hands, face and nose as well as swelling of the upper lip. Parasitological examination of ulcer lesion revealed presence of amastigotes, and the patient was diagnosed with mucocutaneous leishmaniasis. He was treated with sodium stibogluconate (20 mg/kg/day IM for 30 days) and clinically cured. After two years, he presented with clinical outcomes typical of diffuse cutaneous leishmaniasis. After confirmation by parasitological examination, he was put on sodium stibogluconate (20 mg/kg/day IM for 30 days) and paromomycin (15 mg/kg/day IM for 30 days) combination therapy. As he showed no progress, he was treated with prolonged sodium stibogluconate (20 mg/kg/day IM for 60 days) monotherapy. He was still nonresponsive and discharged uncured.Conclusion: The present case is unusual in Ethiopia with relapse of mucocutaneous leishmaniasis progressing to diffuse form. The later form was nonresponsive for both mono and combination therapy, therefore, formulating new drugs or evaluating other anti-Leishmania drugs is required.Keywords: mucocutaneous leishmaniasis, diffuse cutaneous leishmaniasis, case report
first_indexed 2024-12-12T18:18:27Z
format Article
id doaj.art-629728c1298445d29b3d3306874ba886
institution Directory Open Access Journal
issn 1179-142X
language English
last_indexed 2024-12-12T18:18:27Z
publishDate 2020-10-01
publisher Dove Medical Press
record_format Article
series International Medical Case Reports Journal
spelling doaj.art-629728c1298445d29b3d3306874ba8862022-12-22T00:16:12ZengDove Medical PressInternational Medical Case Reports Journal1179-142X2020-10-01Volume 1355155558296Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case ReportTegegne BAlemu GBanchamlak Tegegne,1 Getaneh Alemu2 1Amhara Public Health Institute, Bahir Dar, Ethiopia; 2Department of Medical Laboratory Science, Bahir Dar University, Bahir Dar, EthiopiaCorrespondence: Getaneh Alemu PO Box 79 Tel +251922842776Email getanehmlt@gmail.comBackground: Leishmaniasis is one of the neglected tropical diseases, yet it is associated with high mortality and morbidity. It is caused by intracellular protozoan parasites of the genus Leishmania. Based on the infecting parasite species and host factors, leishmaniasis could be manifested as cutaneous (localized or diffuse), mucocutaneous or visceral clinical forms. In Ethiopia, L. aethiopica is well known to cause all forms of cutaneous leishmaniasis, the localized form being mostcommon.Case Presentation: An adult patient from Yayu district, west Oromia region of Ethiopia presents with multiple skin lesions on his face, hands and mutilation of nose through both nostrils. Eight years before the present symptoms, he has developed spontaneously healed cutaneous ulcer on his face leaving a permanent scar. Physical examination revealed multiple nodular lesions on his hands, face and nose as well as swelling of the upper lip. Parasitological examination of ulcer lesion revealed presence of amastigotes, and the patient was diagnosed with mucocutaneous leishmaniasis. He was treated with sodium stibogluconate (20 mg/kg/day IM for 30 days) and clinically cured. After two years, he presented with clinical outcomes typical of diffuse cutaneous leishmaniasis. After confirmation by parasitological examination, he was put on sodium stibogluconate (20 mg/kg/day IM for 30 days) and paromomycin (15 mg/kg/day IM for 30 days) combination therapy. As he showed no progress, he was treated with prolonged sodium stibogluconate (20 mg/kg/day IM for 60 days) monotherapy. He was still nonresponsive and discharged uncured.Conclusion: The present case is unusual in Ethiopia with relapse of mucocutaneous leishmaniasis progressing to diffuse form. The later form was nonresponsive for both mono and combination therapy, therefore, formulating new drugs or evaluating other anti-Leishmania drugs is required.Keywords: mucocutaneous leishmaniasis, diffuse cutaneous leishmaniasis, case reporthttps://www.dovepress.com/progress-of-mucocutaneous-leishmaniasis-to-drug-nonresponsive-diffuse--peer-reviewed-article-IMCRJmucocutaneous leishmaniasisdiffuse cutaneous leishmaniasiscase report
spellingShingle Tegegne B
Alemu G
Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
International Medical Case Reports Journal
mucocutaneous leishmaniasis
diffuse cutaneous leishmaniasis
case report
title Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
title_full Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
title_fullStr Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
title_full_unstemmed Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
title_short Progress of Mucocutaneous Leishmaniasis to Drug Nonresponsive Diffuse Cutaneous Leishmaniasis in Ethiopia. A Case Report
title_sort progress of mucocutaneous leishmaniasis to drug nonresponsive diffuse cutaneous leishmaniasis in ethiopia a case report
topic mucocutaneous leishmaniasis
diffuse cutaneous leishmaniasis
case report
url https://www.dovepress.com/progress-of-mucocutaneous-leishmaniasis-to-drug-nonresponsive-diffuse--peer-reviewed-article-IMCRJ
work_keys_str_mv AT tegegneb progressofmucocutaneousleishmaniasistodrugnonresponsivediffusecutaneousleishmaniasisinethiopiaacasereport
AT alemug progressofmucocutaneousleishmaniasistodrugnonresponsivediffusecutaneousleishmaniasisinethiopiaacasereport